Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Cardiovascular Systems, Aerolase Sign Agreement for Laser Atherectomy Technology

Photonics.com
Aug 2018
ST. PAUL, Minn., Aug. 7, 2018 — Cardiovascular Systems Inc. (CSI), a medical device company that develops and commercializes interventional treatment systems for patients with peripheral and coronary artery disease, has signed an agreement with Aerolase Corp. to co-develop a new laser atherectomy device for physicians to use in more effectively treating multiple forms of arterial disease.

Under the terms of the agreement, CSI made an undisclosed equity investment in Aerolase and will make additional equity investments as development milestones are met.

Aerolase Corp., based in Tarrytown, N.Y., manufactures, markets, and sells LightPod dermatology lasers.

Cardiovascular Systems Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease.

BusinessBiophotonicsmedicalmedicinelasersarterial diseaseAerolaseAerolase Corp.Cardiovascular SystemsCardiovascular Systems Inc.Americascoronary disease

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.